MDG1015
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MDG1015, covering 2024-12-27 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: EPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma [Phase 1]